NovoCure Surges Over FDA Acceptance Of The PMA Application For TTFields Therapy

NovoCure Limited (NVCR) stock surged 17 percent on Thursday after it announced that FDA has approved its Premarket Approval or PMA application based on the LUNAR, which mentioned the usage of TTFields therapy for the treatment of non-small cell lung cancer or NSCLC.

Related Keywords

Taiwan , Pompton Plains , New Jersey , United States , Sheryl Sandberg , Drug Administration , Facebook , Meta Platforms Inc , Taiwan Semiconductor Manufacturing Co , Taiwan Semiconductor Manufacturing , Chief Operating Officer , Meta Platforms , Salad Kits , Element Farms , Novocure , Oncology Company ,